canyon landscape

StrokeNet Arcadia CSI: Cognition and Silent Infarcts

Home / Patient Care / Take Action / Find a Clinical Trial / Clinical Trials / StrokeNet Arcadia CSI: Cognition and Silent Infarcts

This is a research study looking to compare the effects (good and bad) of the ARCADIA study drugs (apixaban and aspirin) on the occurrence of silent strokes and memory loss after stroke. Your participation is entirely voluntary. This add-on study to the ARCADIA trial involves cognitive testing (tests designed to measure your memory, thinking, reasoning and understanding) and an MRI scan of your brain.

About 500 people will take part in this study.

Status
Open and enrolling subjects.
Location
Phoenix, Arizona
Total Participants
1100
Keywords
Primary Sponsor
Columbia University
Additional Sponsor(s)
National Institute of Neurological Disorders and Stroke (NINDS)
University of Cincinnati
Medical University of South Carolina
Bristol-Myers Squibb
Pfizer
Roche Pharma AG
Weill Medical College of Cornell University
University of Washington